Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul 25:9:951.
doi: 10.3389/fphys.2018.00951. eCollection 2018.

Mechanobiological Feedback in Pulmonary Vascular Disease

Affiliations
Review

Mechanobiological Feedback in Pulmonary Vascular Disease

Paul B Dieffenbach et al. Front Physiol. .

Abstract

Vascular stiffening in the pulmonary arterial bed is increasingly recognized as an early disease marker and contributor to right ventricular workload in pulmonary hypertension. Changes in pulmonary artery stiffness throughout the pulmonary vascular tree lead to physiologic alterations in pressure and flow characteristics that may contribute to disease progression. These findings have led to a greater focus on the potential contributions of extracellular matrix remodeling and mechanical signaling to pulmonary hypertension pathogenesis. Several recent studies have demonstrated that the cellular response to vascular stiffness includes upregulation of signaling pathways that precipitate further vascular remodeling, a process known as mechanobiological feedback. The extracellular matrix modifiers, mechanosensors, and mechanotransducers responsible for this process have become increasingly well-recognized. In this review, we discuss the impact of vascular stiffening on pulmonary hypertension morbidity and mortality, evidence in favor of mechanobiological feedback in pulmonary hypertension pathogenesis, and the major contributors to mechanical signaling in the pulmonary vasculature.

Keywords: YAP/TAZ; cellular mechanosensors; matrix stiffness; mechanotransduction; pulmonary arterial stiffness; pulmonary hypertension; vascular remodeling; vascular stiffness.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Pulmonary arterial stiffening in PAH pathogenesis.
FIGURE 2
FIGURE 2
Mechanisms of mechanobiological feedback.

References

    1. Abe K., Shimokawa H., Morikawa K., Uwatoku T., Oi K., Matsumoto Y., et al. (2004). Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ. Res. 94 385–393. 10.1161/01.RES.0000111804.34509.94 - DOI - PubMed
    1. Abe K., Tawara S., Oi K., Hizume T., Uwatoku T., Fukumoto Y., et al. (2006). Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice. J. Cardiovasc. Pharmacol. 48 280–285. 10.1097/01.fjc.0000248244.64430.4a - DOI - PubMed
    1. Ahn S. J., Fancher I. S., Bian J. T., Zhang C. X., Schwab S., Gaffin R., et al. (2017). Inwardly rectifying K+ channels are major contributors to flow-induced vasodilatation in resistance arteries. J. Physiol. 595 2339–2364. 10.1113/JP273255 - DOI - PMC - PubMed
    1. Alam S. G., Zhang Q., Prasad N., Li Y., Chamala S., Kuchibhotla R., et al. (2016). The mammalian LINC complex regulates genome transcriptional responses to substrate rigidity. Sci. Rep. 6:38063. 10.1038/srep38063 - DOI - PMC - PubMed
    1. Alapati D., Rong M., Chen S., Hehre D., Hummler S. C., Wu S. (2014). Inhibition of beta-catenin signaling improves alveolarization and reduces pulmonary hypertension in experimental bronchopulmonary dysplasia. Am. J. Respir. Cell Mol. Biol. 51 104–113. 10.1165/rcmb.2013-0346OC - DOI - PubMed

LinkOut - more resources